Back to discover
Drug

4-Cresol

Research stage
Emerging research

Also known as PARA-CRESOL.

2
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
4-Cresol
Aliases & brands
PARA-CRESOL
RxNorm CUI
2467144
ChEMBL ID
CHEMBL16645
UNII
1MXY2UM8NV

Research activity

2 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Major research themes4
Cresols1Gastrointestinal Microbiome1Glucagon-Like Peptide 11Myocardial Infarction1
Journals, researchers & institutions
Top journals
  • European heart journal1
  • Frontiers in endocrinology1
Leading researchers
  • Bäckhed F2
  • Arora T1
  • Buffa JA1
  • Demuth I1
  • Fischbach MA1
  • Gillum MP1
  • Haghikia A1
  • Hazen SL1
Leading institutions
free-text, unnormalised
  • Wallenberg Laboratory2
  • and Thoracic Institute1
  • Biomedical Innovation Academy1
  • Center for Microbiome & Human Health1
  • Center for Regenerative Therapies1
  • Charité-Universitätsmedizin Berlin1

Related drugs

2 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across the same disease area as 4-Cresol in the shared literature.

1 shared disease1 shared paper

Frequently co-studied with 4-Cresol in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature